Oasmia Pharmaceutical AB (publ)
Interim report for the period May - October 2010
THE NEW SHARE ISSUE COMPLETED
THE PERIOD May 1 2010 - October 31 2010
• Consolidated net sales amounted to TSEK 42 (24 911)
• Operating income amounted to TSEK -27 047 (1 905)
• Net income after tax amounted to TSEK -28 819 (21)
• Earnings per share was SEK -0,75 (0,00)
• Comprehensive income amounted to TSEK -28 819 (21)
SECOND QUARTER August 1 2010 - October 31 2010
• Consolidated net sales amounted to TSEK 0 (253)
• Operating income amounted to TSEK -15 832 (-8 719)
• Net income after tax amounted to TSEK -16 729 (-9 365)
• Earnings per share was SEK -0,44 (-0,26)
• Comprehensive income amounted to TSEK -16 729 (-9 365)
• Oasmia Pharmaceutical AB announces a fully committed and underwritten rights
issue of SEK 239 million
• The Annual General Meeting elects Björn Björnsson as a new Member of the Board
• The Annual General Meeting makes a resolution of an authorization
corresponding to 15 million shares
• Oasmia appoints Carnegie Investment Bank AB as financial advisor.
• New credit facility of SEK 40 million
EVENTS AFTER CLOSING DAY
• The new share issue is completed
